Log In
Print this Print this

Apidra, insulin glulisine

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionHuman insulin analog produced by recombinant DNA technology
Molecular Target Insulin receptor (INSR)
Mechanism of ActionInsulin receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat hyperglycemia in Type II diabetics undergoing general surgery; Treat pediatric diabetes; Treat Type I and Type II diabetes; Treat Type I diabetes; Treat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today